TYMP and ovarian cancer: 4MU inhibited ovarian cancer cell proliferation in vitro, without affecting migration and invasion. In a peritoneal carcinomatosis model, 4MU inhibited tumor growth and prolonged survival. The authors suggest that thymidine phosphorylase inhibition is the reason for this anti-cancer activity.